Sofidel’s Kisa plant in Sweden gears up to begin fossil-free tissue production

Sofidel has signed a renewable gas supply agreement to replace fossil gas production in under two years at its Kisa plant, a move which will reduce its CO2 emissions by 8,500tpy.

The 10-year agreement has been developed with Meva Energy and in collaboration with the Burner Solution group of Andritz and Örebro Gasteknik.

Meva Energy will operate the thermochemical conversion plant with the capacity of generating at least 4,2 MW gas within the premises of the Kisa plant, and renewable syngas then delivered for 10 years.

Luigi Lazzareschi, Chief Executive of Sofidel Group, said: “We believe in building an inclusive and sustainable future and in our commitment to minimise our impacts on natural capital and encourage the transition to a low-carbon economy we are increasingly focusing on renewable energy.

“The renewable gas supply agreement signed with Meva Energy will help Sofidel to achieve its 2030 emission reduction targets, that have been approved by the Science Based Targets initiative (SBTi) as consistent with the reductions needed to limit global warming to well below 2°C under the Paris Agreement.”

By switching to renewable gas, it is estimated that the tissue mill will reduce its CO2 emissions by 8,500tpy compared with the carbon footprint of today’s consumption of fossil LPG.

Roger Svensk, Country Operations Manager at Sofidel Sweden and responsible for the mill in Kisa, said: “We are delighted of this long-term partnership with Meva Energy through which we’ll be able to implement at our production site an innovative technology.

“This supply agreement further strengthens our sustainable development model for responsible long-term growth.

“We hope other manufacturing units will adopt this technology in the years to come.”

Luigi Lazzareschi will be delivering a session on “Sustainability, Stakeholder Capitalism and Shared Value Creation: Sofidel’s Road to the Future Runs Through ESG Reporting” at Tissue World Miami, 16-18 March 2022. View the full agenda and purchase a ticket here.